Categories
Latest Industry Intelligence
DDW has published the first of its new Guide Series, Where is the global innovation [...]
Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and [...]
The UK government has announced its future strategy for batch testing of medicinal products. The new strategy means that the UK will continue to recognise batch testing from the EU/EEA, rather than insisting on duplicative batch testing operations. Post-BREXIT, the pharmaceutical industry urged the UK and the EU to sign a Mutual Recognition Agreement (MRA) […]
Menu ≡ ╳ 
